L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(4-iodophenyl)methyl]amino]pentyl]amino]carbonyl]- manufacturers
- MIP-1072
-
- $2500.00
-
2026-04-21
- CAS:949575-20-6
- Purity:
- Supply Ability: 10g
|
| | L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(4-iodophenyl)methyl]amino]pentyl]amino]carbonyl]- Basic information |
| | L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(4-iodophenyl)methyl]amino]pentyl]amino]carbonyl]- Chemical Properties |
| Boiling point | 767.8±60.0 °C(Predicted) | | density | 1.602±0.06 g/cm3(Predicted) | | pka | 3.77±0.10(Predicted) |
| | L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(4-iodophenyl)methyl]amino]pentyl]amino]carbonyl]- Usage And Synthesis |
| Uses | MIP-1072 is a small molecule specific prostate-specific membrane antigen (PSMA) inhibitor. MIP-1072 inhibits the glutamate carboxypeptidase activity of PSMA with an Ki value of 4.6 nM. MIP-1072 is promising for research of prostate cancer[1]. | | References | [1] Hillier SM, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69(17):6932-40. DOI:10.1158/0008-5472.CAN-09-1682 |
| | L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[(4-iodophenyl)methyl]amino]pentyl]amino]carbonyl]- Preparation Products And Raw materials |
|